{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:56Z","timestamp":1791644276982,"version":"4.3.4"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","award":["Edital PVE A118\/2013"],"award-info":[{"award-number":["Edital PVE A118\/2013"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["310197\/2021-0"],"award-info":[{"award-number":["310197\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["REDE-00140-16"],"award-info":[{"award-number":["REDE-00140-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["AUXPE 3379\/2013"],"award-info":[{"award-number":["AUXPE 3379\/2013"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI141210"],"award-info":[{"award-number":["R21AI141210"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114876","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T02:17:56Z","timestamp":1666837076000},"page":"114876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds"],"prefix":"10.1016","volume":"244","author":[{"given":"Saulo Fehelberg Pinto","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Corr\u00eaa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Pinto","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elany Barbosa da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann H.","family":"Krake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo D.G.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Carlos","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair L.","family":"Siqueira-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Barbosa","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-0601","authenticated-orcid":false,"given":"Rafaela Salgado","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114876_bib1","first-page":"1","article-title":"Chagas disease: from discovery to a worldwide health problem","volume":"49","author":"Lidani","year":"2019","journal-title":"J. Phys. Oceanogr."},{"key":"10.1016\/j.ejmech.2022.114876_bib2","series-title":"Burger's Med. Chem. Drug Discov.","first-page":"1","article-title":"Drug discovery and development for kinetoplastid diseases","author":"Caffrey","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114876_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105107","article-title":"Drug discovery for chagas disease: a viewpoint","volume":"198","author":"Kratz","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2022.114876_bib4","series-title":"Drugs for Neglected Diseases Initiative 2018 Annual Report","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114876_bib5","first-page":"61","article-title":"Human african trypanosomiasis: progress and stagnation","volume":"33","author":"Bottieau","year":"2019","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2022.114876_bib6","first-page":"29","article-title":"New drugs for human african trypanosomiasis: a twenty first century success story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114876_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol resistance in african trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2022.114876_bib9","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/S1473-3099(19)30612-7","article-title":"New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice","volume":"20","author":"Lindner","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114876_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"Mesu","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114876_bib11","series-title":"Man. Clin. Microbiol.","first-page":"2550","article-title":"Mechanisms of resistance to antiparasitic agents","author":"Secor","year":"2015"},{"key":"10.1016\/j.ejmech.2022.114876_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","article-title":"Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert","volume":"193","author":"Campos","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-97490-2","article-title":"The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites","volume":"11","author":"Santos","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114876_bib15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ejmech.2018.08.079","article-title":"Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors","volume":"157","author":"Rocha","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pharmthera.2017.06.004","article-title":"Targeting cysteine proteases in trypanosomatid disease drug discovery","volume":"180","author":"Ferreira","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2022.114876_bib17","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1016\/S0021-9258(18)53226-9","article-title":"Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi","volume":"268","author":"Eakin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib18","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1016\/S0021-9258(18)42533-1","article-title":"The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi","volume":"267","author":"Eakin","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: current status of available drugs and new potential drug targets","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.ejmech.2022.114876_bib20","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2174\/1568026621666210331152702","article-title":"Cruzain and rhodesain inhibitors: last decade of advances in seeking for new compounds against American and african trypanosomiases","volume":"21","author":"dos Santos Nascimento","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006512","article-title":"Cysteine proteases in protozoan parasites, PLoS Negl","volume":"12","author":"Siqueira-Neto","year":"2018","journal-title":"Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.114876_bib22","series-title":"Compr. Anal. Parasite Biol. From Metab. To Drug Discov.","first-page":"121","article-title":"Trypanosomal cysteine peptidases: target validation and drug design strategies","author":"da Silva","year":"2016"},{"key":"10.1016\/j.ejmech.2022.114876_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2021.111395","article-title":"Should the enzyme name \u2018rhodesain\u2019 be discontinued?","volume":"245","author":"Steverding","year":"2021","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-6851(01)00368-1","article-title":"Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense","volume":"118","author":"Caffrey","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijpara.2012.03.009","article-title":"Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target","volume":"42","author":"Steverding","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI27798C1","article-title":"Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease","volume":"118","author":"Nikolskaia","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.114876_bib27","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.bmc.2017.02.009","article-title":"Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification","volume":"25","author":"Braga","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib28","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib29","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/acs.jmedchem.9b00683","article-title":"Can cysteine protease cross-class inhibitors achieve selectivity?","volume":"62","author":"Cianni","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejmech.2019.06.062","article-title":"Discovery and characterization of trypanocidal cysteine protease inhibitors from the \u2018malaria box","volume":"179","author":"Pereira","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005763","article-title":"Open source drug discovery with the malaria box compound collection for neglected diseases and beyond","volume":"12","author":"Van Voorhis","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2022.114876_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria box: a drug discovery catalyst for neglected diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114876_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ejmech.2016.12.024","article-title":"Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans","volume":"126","author":"Krake","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib34","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114876_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/C9MD00458K","article-title":"Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents","volume":"11","author":"Malik","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib36","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1021\/jm030266r","article-title":"A specific mechanism of nonspecific inhibition","volume":"46","author":"McGovern","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib37","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/jm020427b","article-title":"Kinase inhibitors: not just for kinases anymore","volume":"46","author":"McGovern","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.drudis.2006.05.014","article-title":"Screening in a spirit haunted world","volume":"11","author":"Shoichet","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114876_bib39","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib40","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2015.06.048","article-title":"Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain","volume":"101","author":"Esp\u00edndola","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib41","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/AAC.04601-14","article-title":"Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1","volume":"59","author":"Fonseca","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114876_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bmcl.2004.10.023","article-title":"Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain","volume":"15","author":"Fujii","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114876_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2018.11.013","article-title":"Thiazole, thio and semicarbazone derivatives against tropical infective diseases: chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria","volume":"162","author":"Scarim","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib44","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.2174\/0929867324666171023163752","article-title":"Privileged structures in the design of potential drug candidates for neglected diseases","volume":"26","author":"Leite","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm901070c","article-title":"Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease","volume":"53","author":"Jadhav","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib46","doi-asserted-by":"crossref","first-page":"13054","DOI":"10.1021\/acs.jmedchem.1c01151","article-title":"Structure-based optimization of quinazolines as cruzain and tbr CATL inhibitors","volume":"64","author":"Barbosa da Silva","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib47","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1016\/j.bmc.2011.09.037","article-title":"Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents","volume":"19","author":"Caputto","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib48","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.bmc.2010.09.056","article-title":"Studies toward the structural optimization of novel thiazolylhydrazone- based potent antitrypanosomal agents","volume":"18","author":"Hernandes","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejmech.2013.04.022","article-title":"Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates","volume":"67","author":"Blau","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejmech.2014.02.001","article-title":"Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death","volume":"75","author":"Magalhaes Moreira","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","article-title":"2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation","volume":"86","author":"Cardoso","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1087057114556236","article-title":"Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR green assay for trypanosoma brucei","volume":"20","author":"Faria","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2022.114876_bib53","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1021\/acs.jmedchem.9b00294","article-title":"Design of gallinamide A analogs as potent inhibitors of the cysteine proteases human cathepsin L and trypanosoma cruzi cruzain","volume":"62","author":"Boudreau","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2016.10.006","article-title":"Synthesis of 1,2,3-triazole hydrazide derivatives exhibiting anti-phytopathogenic activity","volume":"126","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib55","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1590\/S0100-40422011001000012","article-title":"A rea\u00e7\u00e3o \u201cclick\u201d na s\u00edntese de 1,2,3-triaz\u00f3is: aspectos qu\u00edmicos e aplica\u00e7\u00f5es","volume":"34","author":"Freitas","year":"2011","journal-title":"Quim. Nova"},{"key":"10.1016\/j.ejmech.2022.114876_bib56","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ejmech.2011.01.031","article-title":"Design, synthesis and antifungal activities of novel pyrrole alkaloid analogs","volume":"46","author":"Wang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib57","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1021\/jo960057x","article-title":"Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination Procedures1","volume":"61","author":"Abdel-Magid","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib58","first-page":"10827","volume":"61","author":"Montalbetti","year":"2005","journal-title":"Amide bond formation and peptide coupling"},{"key":"10.1016\/j.ejmech.2022.114876_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S0100-40422008000200013","article-title":"S\u00edntese, avalia\u00e7\u00e3o biol\u00f3gica e modelagem molecular de arilfuranos como inibidores da enzima tripanotiona redutase","volume":"31","author":"De Oliveira","year":"2008","journal-title":"Quim. Nova"},{"key":"10.1016\/j.ejmech.2022.114876_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mrc.4041","article-title":"Synthesis, NMR structural characterization and molecular modeling of substituted thiosemicarbazones and semicarbazones using DFT calculations to prove the syn\/anti isomer formation","volume":"52","author":"Venkatachalam","year":"2014","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib61","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/jm061317y","article-title":"A high-throughput screen for aggregation-based inhibition in a large compound library","volume":"50","author":"Feng","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib62","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/jm701500e","article-title":"Comprehensive mechanistic analysis of hits from high-throughput and docking screens against \u03b2-lactamase","volume":"51","author":"Babaoglu","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib63","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm100488w","article-title":"Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib64","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1021\/jm030191r","article-title":"Identification and prediction of promiscuous aggregating inhibitors among known drugs","volume":"46","author":"Seidler","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib65","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/jm9009229","article-title":"Divergent modes of enzyme inhibition in a homologous Structure\u2212Activity series","volume":"52","author":"Ferreira","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib66","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/jm700952v","article-title":"Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors","volume":"51","author":"Giannetti","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib67","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/j.bmcl.2006.05.041","article-title":"Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas\u2019 disease","volume":"16","author":"Siles","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114876_bib68","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1016\/j.bmc.2015.10.048","article-title":"Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi","volume":"23","author":"De Oliveira Filho","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib69","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bmc.2016.02.027","article-title":"Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi","volume":"24","author":"Costa","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib70","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejmech.2007.06.020","article-title":"4-Nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity","volume":"43","author":"P\u00e9rez-Rebolledo","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib71","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.ejmech.2010.01.052","article-title":"Naftifine-analogues as anti-Trypanosoma cruzi agents","volume":"45","author":"Gerpe","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib72","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.ejmech.2010.09.034","article-title":"Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity","volume":"45","author":"\u00c1lvarez","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejmech.2014.09.027","article-title":"In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi","volume":"87","author":"Moreno-Rodr\u00edguez","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","article-title":"Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi","volume":"111","author":"De Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2017.02.026","article-title":"Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death","volume":"130","author":"da Silva","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib76","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2018.01.043","article-title":"Aryl thiosemicarbazones for the treatment of trypanosomatidic infections","volume":"146","author":"Linciano","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2019.07.018","article-title":"2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: structural design, synthesis and antiparasitic activity","volume":"180","author":"Cardoso","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib78","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1021\/jm500018m","article-title":"Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity","volume":"57","author":"\u00c1lvarez","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1039\/c0md00085j","article-title":"Development of second generation amidinohydrazones, thio- and semicarbazones as Trypanosoma cruzi-inhibitors bearing benzofuroxan and benzimidazole 1,3-dioxide core scaffolds","volume":"1","author":"Merlino","year":"2010","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2022.114876_bib80","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1016\/j.bmc.2008.05.038","article-title":"New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle","volume":"16","author":"Porcal","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib81","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1016\/j.bmc.2009.09.013","article-title":"5-Nitrofuranes and 5-nitrothiophenes with anti-trypanosoma cruzi activity and ability to accumulate squalene","volume":"17","author":"Gerpe","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib82","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/jm030549j","article-title":"Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi","volume":"47","author":"Greenbaum","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib83","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1021\/jm7014292","article-title":"Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives","volume":"51","author":"Papanastasiou","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib84","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00044-012-0208-6","article-title":"Structure-activity relationship study of thiosemicarbazones on an African trypanosome: trypanosoma brucei brucei","volume":"22","author":"Fatondji","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.114876_bib85","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.bmc.2010.02.034","article-title":"Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi","volume":"18","author":"Watts","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib86","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1016\/j.bmcl.2008.03.083","article-title":"Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB","volume":"18","author":"Mallari","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114876_bib87","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2019.04.052","article-title":"Thiazolidinone\/thiazole based hybrids \u2013 new class of antitrypanosomal agents","volume":"174","author":"Kryshchyshyn","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114876_bib88","series-title":"WEHI\/Eskitis Trypanosoma B. Brucei Screening Data","author":"Sykes","year":"2013"},{"key":"10.1016\/j.ejmech.2022.114876_bib89","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114876_bib90","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114876_bib91","series-title":"Modified HMI-9* - for 10 Liters for Bloodstream Forms","year":"2008"},{"key":"10.1016\/j.ejmech.2022.114876_bib92","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cmdc.201800404","article-title":"Brain-penetrant triazolopyrimidine and phenylpyrimidine microtubule stabilizers as potential leads to treat human african trypanosomiasis","volume":"13","author":"Monti","year":"2018","journal-title":"ChemMedChem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:04:04Z","timestamp":1777529044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422007784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":92,"alternative-id":["S0223523422007784"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114876","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114876"}}